Is Platelet Function as Measured by Thrombelastograph Monitoring in Whole Blood Affected by Platelet Inhibitors?
Platelet inhibitors, especially the glycoprotein (GP) IIb/IIIa receptor antagonists, have demonstrated their effectiveness in reducing the acute ischemic complications of percutaneous coronary intervention (PCI) and in improving clinical outcomes in patients with acute coronary crisis.
